Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.73 CHF | +1.18% |
|
+0.79% | -6.33% |
Jul. 02 | Ascom, Almaviva Team Up for Healthcare Digitalization in Italy | MT |
Jun. 12 | Ascom Secures Five-year Contract to Deploy Digital Alerts System for Children’s Hospital in Ireland | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 378.3 | 471.3 | 423.3 | 266.8 | 295.2 | 274.4 | - | - |
Enterprise Value (EV) 1 | 400.1 | 458.5 | 393.8 | 256.4 | 275.9 | 248.5 | 242.6 | 236.1 |
P/E ratio | 1,052 x | 72.8 x | 31.8 x | 24.8 x | 17.1 x | 15 x | 12.6 x | 10.8 x |
Yield | 4.28% | - | 1.7% | 2.69% | 3.65% | 4.14% | 5.24% | 5.67% |
Capitalization / Revenue | 1.34 x | 1.68 x | 1.45 x | 0.9 x | 0.99 x | 0.91 x | 0.87 x | 0.82 x |
EV / Revenue | 1.41 x | 1.63 x | 1.35 x | 0.86 x | 0.93 x | 0.83 x | 0.76 x | 0.7 x |
EV / EBITDA | 500 x | 18.4 x | 13.7 x | 10.7 x | 9.17 x | 7.5 x | 6.43 x | 5.54 x |
EV / FCF | -29.6 x | 13.3 x | -3,938 x | -80.1 x | 16.9 x | 16.9 x | 15.9 x | 12.1 x |
FCF Yield | -3.37% | 7.5% | -0.03% | -1.25% | 5.91% | 5.92% | 6.31% | 8.26% |
Price to Book | 5.98 x | 6.65 x | 5.3 x | 3.64 x | 3.75 x | 3.14 x | 2.84 x | 2.56 x |
Nbr of stocks (in thousands) | 35,962 | 35,978 | 35,993 | 35,915 | 35,909 | 35,917 | - | - |
Reference price 2 | 10.52 | 13.10 | 11.76 | 7.430 | 8.220 | 7.640 | 7.640 | 7.640 |
Announcement Date | 3/5/20 | 3/11/21 | 3/9/22 | 3/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 282.9 | 281 | 291.5 | 297.4 | 297.3 | 300.8 | 317.2 | 335.2 |
EBITDA 1 | 0.8 | 24.9 | 28.7 | 23.9 | 30.1 | 33.15 | 37.74 | 42.62 |
EBIT 1 | -13.4 | 11 | 15.8 | 14 | 20.2 | 22.55 | 27.13 | 31.9 |
Operating Margin | -4.74% | 3.91% | 5.42% | 4.71% | 6.79% | 7.5% | 8.55% | 9.52% |
Earnings before Tax (EBT) 1 | -2.6 | 7.8 | 17.2 | 14.9 | - | 22 | 26.5 | 30.5 |
Net income 1 | 0.5 | 6.5 | 13.5 | 11 | 17.4 | 18.11 | 21.64 | 25.08 |
Net margin | 0.18% | 2.31% | 4.63% | 3.7% | 5.85% | 6.02% | 6.82% | 7.48% |
EPS 2 | 0.0100 | 0.1800 | 0.3700 | 0.3000 | 0.4800 | 0.5089 | 0.6045 | 0.7058 |
Free Cash Flow 1 | -13.5 | 34.4 | -0.1 | -3.2 | 16.3 | 14.7 | 15.3 | 19.5 |
FCF margin | -4.77% | 12.24% | -0.03% | -1.08% | 5.48% | 4.89% | 4.82% | 5.82% |
FCF Conversion (EBITDA) | - | 138.15% | - | - | 54.15% | 44.35% | 40.54% | 45.75% |
FCF Conversion (Net income) | - | 529.23% | - | - | 93.68% | 81.16% | 70.69% | 77.76% |
Dividend per Share 2 | 0.4500 | - | 0.2000 | 0.2000 | 0.3000 | 0.3167 | 0.4000 | 0.4333 |
Announcement Date | 3/5/20 | 3/11/21 | 3/9/22 | 3/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
---|---|---|---|---|---|---|---|
Net sales 1 | 133.4 | 140.1 | 151.4 | 143.8 | 153.6 | 150.2 | 147.1 |
EBITDA | 8.4 | 10.1 | 18.6 | 6.9 | 17 | 11.2 | - |
EBIT | 1 | 3.4 | 12.4 | 1.7 | - | 6.1 | - |
Operating Margin | 0.75% | 2.43% | 8.19% | 1.18% | - | 4.06% | - |
Earnings before Tax (EBT) | - | - | 13.2 | -2.6 | - | 7.1 | - |
Net income | -0.3 | 2.5 | 11 | -2.3 | 13.3 | 5.1 | - |
Net margin | -0.22% | 1.78% | 7.27% | -1.6% | 8.66% | 3.4% | - |
EPS | - | 0.0700 | - | - | 0.3600 | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 8/13/20 | 8/19/21 | 3/9/22 | 8/11/22 | 3/8/23 | 8/9/23 | 3/5/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 21.8 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 12.8 | 29.5 | 10.4 | 19.3 | 25.9 | 31.8 | 38.3 |
Leverage (Debt/EBITDA) | 27.25 x | - | - | - | - | - | - | - |
Free Cash Flow 1 | -13.5 | 34.4 | -0.1 | -3.2 | 16.3 | 14.7 | 15.3 | 19.5 |
ROE (net income / shareholders' equity) | 0.68% | 9.68% | 17.9% | 14.3% | 22.9% | 21.9% | 23.8% | 24.9% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 1.760 | 1.970 | 2.220 | 2.040 | 2.190 | 2.430 | 2.690 | 2.990 |
Cash Flow per Share 2 | 0.0800 | 1.250 | 0.3200 | 0.2800 | 0.9000 | 0.5200 | 0.9200 | 1.070 |
Capex 1 | 16.4 | 10.7 | 11.7 | 13.4 | 16.2 | 14.2 | 13.9 | 14.3 |
Capex / Sales | 5.8% | 3.81% | 4.01% | 4.51% | 5.45% | 4.7% | 4.37% | 4.27% |
Announcement Date | 3/5/20 | 3/11/21 | 3/9/22 | 3/8/23 | 3/5/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.06% | 305M | |
-8.41% | 186B | |
+54.45% | 114B | |
+91.47% | 79.05B | |
+24.90% | 65.22B | |
+27.16% | 31.4B | |
+95.33% | 23.77B | |
+19.35% | 21.71B | |
+7.65% | 21.49B | |
+8.95% | 17.8B |
- Stock Market
- Equities
- ASCN Stock
- Financials Ascom Holding AG